Cargando…

Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone

Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitara, Despina, Kim, Somi, Razzaque, Mohammed S., Bergwitz, Clemens, Taguchi, Takashi, Schüler, Christiane, Erben, Reinhold G., Lanske, Beate
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483943/
https://www.ncbi.nlm.nih.gov/pubmed/18688277
http://dx.doi.org/10.1371/journal.pgen.1000154
Descripción
Sumario:Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regulation is not yet completely understood. Targeted disruption of the Fgf-23 gene in mice (Fgf-23(−/−)) elicits hyperphosphatemia, and an increase in renal sodium/phosphate co-transporter 2a (NaPi2a) protein abundance. To elucidate the pathophysiological role of augmented renal proximal tubular expression of NaPi2a in Fgf-23(−/−) mice and to examine serum phosphate–independent functions of Fgf23 in bone, we generated a new mouse line deficient in both Fgf-23 and NaPi2a genes, and determined the effect of genomic ablation of NaPi2a from Fgf-23(−/−) mice on phosphate homeostasis and skeletal mineralization. Fgf-23(−/−)/NaPi2a(−/−) double mutant mice are viable and exhibit normal physical activities when compared to Fgf-23(−/−) animals. Biochemical analyses show that ablation of NaPi2a from Fgf-23(−/−) mice reversed hyperphosphatemia to hypophosphatemia by 6 weeks of age. Surprisingly, despite the complete reversal of serum phosphate levels in Fgf-23(−/−)/NaPi2a(−/−), their skeletal phenotype still resembles the one of Fgf23(−/−) animals. The results of this study provide the first genetic evidence of an in vivo pathologic role of NaPi2a in regulating abnormal phosphate homeostasis in Fgf-23(−/−) mice by deletion of both NaPi2a and Fgf-23 genes in the same animal. The persistence of the skeletal anomalies in double mutants suggests that Fgf-23 affects bone mineralization independently of systemic phosphate homeostasis. Finally, our data support (1) that regulation of phosphate homeostasis is a systemic effect of Fgf-23, while (2) skeletal mineralization and chondrocyte differentiation appear to be effects of Fgf-23 that are independent of phosphate homeostasis.